Danny Dearen - Axonics Modulation Chief Operating and Financial Officer
AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Executive
Mr. Danny L. Dearen is the Chief Operating and Financial Officer of the Company. He has over 20 years of experience in medical devices and pharmaceutical industries. Previously Chief Operating and Financial Officer at Vessix Vascular, Mr. Dearen was responsible for integration following the acquisition of Vessix by Boston Scientific. Prior to that, Mr. Dearen was CFO of a number of life science and VC firms including Miraval Holding, Q3DM, Fairbanks Systems Group, ESI Software, Medication Delivery Devices and positions with Ventana Growth Funds.
Age | 61 |
Phone | 949 396 6322 |
Web | https://www.axonics.com |
Axonics Modulation Management Efficiency
Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.Axonics Modulation Technologies currently holds 27.62 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Axonics Modulation has a current ratio of 10.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Axonics Modulation's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Daniel JD | Orthopediatrics Corp | 54 | |
Guy Yoskovitz | Nano X Imaging | 45 | |
Mei Jiang | Medtronic PLC | N/A | |
Orit MD | Nano X Imaging | 53 | |
Nikolas Kerr | Si Bone | 52 | |
Que Dallara | Medtronic PLC | 50 | |
Anthony Recupero | Si Bone | 65 | |
Gregory Smith | Medtronic PLC | 60 | |
Jane Rady | Glaukos Corp | 76 | |
Matt Walter | Medtronic PLC | N/A | |
Michael Pisetsky | Si Bone | 46 | |
Noga Shabshin | Nano X Imaging | N/A | |
Kamran Shamaei | Monogram Orthopaedics Common | 41 | |
Jill Mason | Orthofix Medical | N/A | |
Andrew Senn | Integer Holdings Corp | 42 | |
Amy Treadwell | Neuropace | N/A | |
Andres Cedron | Orthofix Medical | 43 | |
Leah Akin | Neuropace | N/A | |
Julie Andrews | Orthofix Medical | 53 | |
Julie Dewey | Orthofix Medical | 63 | |
Douglas Devine | iRhythm Technologies | 54 |
Management Performance
Return On Equity | -0.0089 | ||||
Return On Asset | -0.0063 |
Axonics Modulation Leadership Team
Elected by the shareholders, the Axonics Modulation's board of directors comprises two types of representatives: Axonics Modulation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axonics. The board's role is to monitor Axonics Modulation's management team and ensure that shareholders' interests are well served. Axonics Modulation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axonics Modulation's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alfred Ford, Chief Commercial Officer | ||
Danny Dearen, Chief Operating and Financial Officer | ||
MD MAS, Chief Officer | ||
Raymond Cohen, CEO, Director | ||
Rinda Sama, Chief Officer | ||
JD Esq, General VP | ||
Aaron Pettit, General Officer | ||
Kari Keese, Chief Officer | ||
John Woock, Chief Marketing Officer | ||
Neil Bhalodkar, Vice Relations | ||
Guangqiang Jiang, Chief Officer |
Axonics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axonics Modulation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0089 | ||||
Return On Asset | -0.0063 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | (0.02) % | ||||
Current Valuation | 3.32 B | ||||
Shares Outstanding | 51.11 M | ||||
Shares Owned By Insiders | 1.26 % | ||||
Shares Owned By Institutions | 87.22 % | ||||
Number Of Shares Shorted | 3.31 M | ||||
Price To Earning | (10.68) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Stocks Directory Find actively traded stocks across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |